Mitochondrial Decay: Why Cellular Power Failure Drives Biological Aging

Overview

At the core of mammalian senescence lies a progressive bioenergetic collapse, a phenomenon molecular gerontologists designate as mitochondrial decay. As extensively catalogued within literature indexed on PubMed, the gradual deterioration of mitochondrial architecture and oxidative phosphorylation (OXPHOS) efficiency is not merely a correlate of chronological ageing, but its primary driver. Within the UK research landscape—most notably spearheaded by groups at the Medical Research Council (MRC) Mitochondrial Biology Unit in Cambridge—investigation has shifted from viewing mitochondrial dysfunction as a passive casualty of cellular wear-and-tear to recognising it as an active, self-perpetuating initiator of systemic systemic degradation.

The mechanics of this decay are rooted in the electron transport chain (ETC). During normal oxidative metabolism, Complexes I and III inevitably leak electrons that prematurely reduce molecular oxygen, generating superoxide radicals. Under youthful homeostatic conditions, endogenous antioxidant enzymes such as manganese superoxide dismutase (SOD2) and glutathione peroxidase neutralise these reactive oxygen species (ROS). However, a vicious cycle ensues: accumulated ROS oxidatively damage the very mitochondrial DNA (mtDNA) encoding critical ETC subunits. Lacking protective histones and possessing rudimentary repair mechanisms compared to nuclear DNA, mtDNA mutates at a rate approximately tenfold higher. This gives rise to respiratory-deficient cells that produce less ATP and disproportionately more ROS, accelerating systemic macromolecular damage across lipid membranes, nuclear DNA, and structural proteins.

Simultaneously, the dynamic equilibrium of mitochondrial network morphology—governed by continuous cycles of fusion (mediated by mitofusins and OPA1) and fission (driven by Drp1)—becomes severely dysregulated with age. Senescent cells typically exhibit fragmented, hyper-fused, or enlarged, dysfunctional mitochondria that evade quality control clearance. While mitophagy (the selective macroautophagic degradation of damaged mitochondria) initially attempts to purge this bioenergetic debris, autophagic flux declines progressively with age. Consequently, oxidised proteins and dysfunctional organelles accumulate within the cytosol, triggering chronic, sterile inflammation through the activation of the NLRP3 inflammasome and cGAS-STING pathways—a state recently termed "inflammageing" by British immunologists.

At INNERSTANDIN, we dissect these cascading failure points to reveal the foundational biology of human ageing. When mitochondrial membrane potential ($\Delta\psi_m$) collapses, the threshold for cytochrome c release drops, prematurely engaging intrinsic apoptosis across post-mitotic tissues such as the myocardium, skeletal muscle, and central nervous system. Understanding mitochondrial decay shifts the paradigm of biogerontology: combating ageing requires not merely treating downstream symptoms, but restoring mitochondrial quality control, biogenesis, and bioenergetic fidelity at the cellular root.

The Biology — How It Works

At the core of mammalian senescence lies a bioenergetic paradox: the very organelle responsible for sustaining life—the mitochondrion—is also the primary engine of its systemic destruction. Through oxidative phosphorylation (OXPHOS), mitochondria generate adenosine triphosphate (ATP) via the electron transport chain (ETC), a process fundamentally dependent on Complexes I through V situated within the inner mitochondrial membrane. However, this metabolic throughput is inherently leaky. Electron slippage at Complexes I and III results in the premature reduction of molecular oxygen, generating reactive oxygen species (ROS), predominantly superoxide radicals ($\text{O}_2^{\bullet-}$). As exhaustively documented in literature from journals such as Cell Metabolism and The Lancet, this baseline oxidative stress initiates a vicious feed-forward loop of macromolecular damage known in biogerontology as the mitochondrial theory of aging.

Unlike nuclear DNA, which is heavily protected by histone octamers and sophisticated nucleotide excision repair complexes, mitochondrial DNA (mtDNA) lacks canonical histones and sits in close spatial proximity to the ETC—the primary site of ROS production. Furthermore, the mitochondrial matrix exhibits a deficient repair toolkit for double-strand breaks, relying primarily on a truncated base excision repair (BER) pathway. Consequently, somatic mtDNA mutation rates are roughly ten times higher than those of nuclear genomes. As demonstrated in landmark transgenic mouse models expressing error-prone mtDNA polymerase gamma (POLG mutators), this mutational load drives a progressive accumulation of deletions and point mutations. The resulting translation errors yield structurally aberrant ETC subunits, compromising super-complex assembly and further exponentially escalating electron leakage and ROS output.

This biochemical breakdown precipitates structural remodeling. Under physiological conditions, mitochondria exist in a state of dynamic equilibrium, cycling continuously between fusion (governed by Mitofusins 1/2 and Opa1) and fission (mediated by Drp1 and Fis1) to segregate and eliminate dysfunctional components. With advancing age, this quality-control axis fractures. Fission outpaces fusion, yielding fragmented, hyper-depolarised organelles incapable of maintaining the mitochondrial membrane potential ($\Delta\Psi_m$) required for ATP synthesis. Simultaneously, mitophagy—the selective macroautophagic clearance of damaged mitochondria via the PINK1-Parkin signalling cascade—becomes blunted. Senescent cells accumulate a mass of dysfunctional, megakaryocytic mitochondria that consume ATP rather than produce it, while continuously flooding the cytosol with damage-associated molecular patterns (DAMPs), including oxidized mtDNA and cardiolipin.

At INNERSTANDIN, we emphasize that this bioenergetic crisis does not remain localized to the cell. Cytosolic release of mitochondrial DAMPs triggers the cyclic GMP-AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway, establishing a chronic, sterile, low-grade systemic inflammation known as 'inflammaging'. Concurrently, cellular ATP depletion deactivates AMP-activated protein kinase (AMPK) and suppresses NAD$^{+}$-dependent sirtuins (SIRT1–SIRT3), locking the cell in a pro-aging transcriptional state characterized by mTOR hyperactivation and stunted autophagy. In post-mitotic tissues—most notably the myocardium, central nervous system, and skeletal muscle—this progressive bioenergetic famine manifests as sarcopenia, neurodegeneration, and metabolic inflexibility. Understanding mitochondrial decay as a driver of systemic failure rather than a mere secondary epiphenomenon is critical for targeting the root mechanisms of human biological aging.

Mechanisms at the Cellular Level

At the foundational level of human physiology, biological aging is inextricably linked to the progressive bioenergetic failure of our subcellular power plants. As catalogued extensively in literature emerging from academic powerhouses such as the MRC Mitochondrial Biology Unit in Cambridge, mitochondrial decay is not merely a passive correlate of senescence; it is a primary driver. The root of this decay lies within a vicious, self-amplifying loop of structural degradation and metabolic inefficiency. Mitochondria rely on a dual-genome system, housing their own compact mitochondrial DNA (mtDNA) in close proximity to the electron transport chain (ETC)—the very site where reactive oxygen species (ROS) are constitutively generated as a byproduct of oxidative phosphorylation. Unlike nuclear DNA, mtDNA lacks protective histone shielding and possesses a rudimentary repair repertoire, rendering it exceptionally vulnerable to oxidative mutagenesis.

As organisms age, somatic mutations in mtDNA accumulate exponentially, leading to aberrant transcription and translation of essential ETC subunits, particularly complexes I, III, IV, and V. This molecular infidelity compromises the structural integrity of the inner mitochondrial membrane, impairing the proton gradient necessary to drive adenosine triphosphate (ATP) synthesis via ATP synthase. Consequently, cellular bioenergetics plummet, depriving energy-demanding tissues—such as neurons, cardiomyocytes, and skeletal muscle fibres—of the ATP required to maintain baseline homeostasis. As demonstrated in landmark studies published in The Lancet and indexed across PubMed, this bioenergetic deficit triggers a critical downstream consequence: electron leakage from the dysfunctional ETC surges, compounding the intracellular oxidant burden and precipitating lipid peroxidation, protein carbonylation, and further genomic damage.

Compounding this biochemical breakdown is the dysregulation of mitochondrial quality control networks, encompassing mitophagy, biogenesis, and mitochondrial dynamics (fusion and fission). Under youthful, homeostatic conditions, damaged organelles are segregated via fission and selectively cleared through PINK1/Parkin-mediated mitophagy. However, biological aging induces a state of chronic mitophagy resistance and transcriptional down-regulation of master regulators like PGC-1alpha (peroxisome proliferator-activated receptor gamma coactivator 1-alpha). The resulting accumulation of senescent, elongated, or fragmented mitochondria chokes the intracellular landscape. These dysfunctional organelles fail to buffer intracellular calcium effectively and prematurely lower the apoptotic threshold by destabilising the outer mitochondrial membrane, releasing cytochrome c into the cytosol.

At INNERSTANDIN, our analysis of recent peer-reviewed data highlights that this compounding cellular dysfunction activates sterile, low-grade systemic inflammation—often termed 'inflammageing'. Escaped mitochondrial damage-associated molecular patterns (DAMPs), including oxidised mtDNA and cardiolipin, leak into the cytosol and extracellular milieu, activating the NLRP3 inflammasome and cGAS-STING pathways. This signalling cascade perpetually primes innate immune responses, driving tissue fibrosis and accelerating the systemic decline characteristic of mammalian aging. Understanding these precise cellular mechanisms shifts our paradigm from treating the superficial manifestations of age-related pathologies to targeting the root bioenergetic decay at the heart of mitochondrial pathobiology.

Environmental Threats and Biological Disruptors

At the heart of the INNERSTANDIN biological education framework lies a critical truth: intracellular longevity is continuously challenged by exogenous and endogenous stressors that accelerate mitochondrial decay. The bioenergetic engine of the human cell does not fail in a vacuum. Contemporary biomedical research indexed in databases such as PubMed and The Lancet consistently demonstrates that environmental disruptors act as catalysts for structural and functional decline in the mitochondrial reticulum. These stressors compromise oxidative phosphorylation (OXPHOS), subvert quality control mechanisms, and drive systemic cellular senescence.

A primary exogenous threat is the pervasive presence of environmental xenobiotics, including persistent organic pollutants, heavy metals such as cadmium and lead, and agrochemicals like rotenone and paraquat. Mechanistically, these compounds frequently localise to the inner mitochondrial membrane, where they inhibit specific complexes of the electron transport chain (ETC). Rotenone, for instance, acts as a potent inhibitor of Complex I (NADH:ubiquinone oxidoreductase). By blocking electron transfer from iron-sulphur centres to ubiquinone, rotenone precipitates an immediate backlog of electrons, resulting in a pathological surge of superoxide radicals ($O_2^{\bullet-}$) and reactive oxygen species (ROS). This localised oxidative stress directly attacks polyunsaturated fatty acids within the cardiolipin-rich inner membrane, initiating lipid peroxidation that structurally deforms cristae and uncouples ATP synthesis from oxygen consumption.

Concurrently, modern dietary patterns and metabolic disruptors—such as chronic exposure to high-fructose diets, endocrine-disrupting chemicals (EDCs) like bisphenol A (BPA), and particulate matter ($PM_{2.5}$) prevalent in urban British environments—exacerbate mitochondrial vulnerability. EDCs have been shown in molecular toxicology studies to bind to oestrogen-related receptors and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-$1\alpha$), the master transcriptional regulator of mitochondrial biogenesis. When PGC-$1\alpha$ expression is suppressed, the cell's capacity to synthesise new, functional mitochondria plummets. Consequently, the relative proportion of damaged, structurally compromised mitochondria increases, overwhelming endogenous antioxidant defences such as superoxide dismutase (SOD2) and glutathione peroxidase.

Furthermore, these environmental insults impair the two primary mitochondrial quality control axes: mitophagy and mitochondrial dynamics (fusion and fission). Under physiological stress, properly functioning cells isolate severely damaged organelles via fission and clear them through PINK1/Parkin-mediated mitophagy. However, chronic exposure to environmental toxins disrupts the mitochondrial membrane potential ($\Delta\Psi_m$), paradoxically locking the fission machinery—chiefly dynamin-related protein 1 (Drp1)—in a state of hyper-activation while downregulating fusogenic proteins like mitofusins (MFN1/2). This imbalance fragments the mitochondrial network into dysfunctional, swollen vesicles incapable of efficient ATP production.

The downstream systemic consequences of these environmental interactions are profound. As oxidatively damaged mitochondrial DNA (mtDNA)—which lacks protective histone coverage and possesses limited repair capacity—accumulates mutations, the synthesis of essential ETC subunits encoded by the mitochondrial genome is compromised. This perpetuates a vicious cycle: damaged ETC complexes leak more electrons, generating higher ROS yields, which in turn inflict further damage on mtDNA, lipids, and proteins. Within tissues with high metabolic demands, such as the myocardium, skeletal muscle, and the central nervous system, this progressive bioenergetic deficit manifests clinically as reduced functional reserve, systemic inflammageing driven by cytosolic mtDNA leakage activating the cGAS-STING pathway, and accelerated biological aging. Unravelling these environmental mechanisms is paramount for developing targeted interventions that preserve mitochondrial integrity and extend human healthspan.

The Cascade: From Exposure to Disease

The transition from isolated mitochondrial insult to systemic pathobiology represents one of the most critical paradigms in contemporary biogerontology. When chronic exposure to endogenous reactive oxygen species (ROS), xenobiotics, and metabolic stressors breaches the antioxidant threshold of the organelle, a self-amplifying cascade is initiated. This degenerative trajectory—frequently documented in seminal publications within The Lancet and various PubMed-indexed journals—begins with the oxidative modification of mitochondrial DNA (mtDNA). Lacking the robust histone protection and sophisticated nucleotide excision repair mechanisms inherent to nuclear DNA, mtDNA sustains somatic mutation rates orders of magnitude higher. As mutant transcripts propagate via relaxed replication, the translation of aberrant electron transport chain (ETC) subunits accelerates, physically destabilising oxidative phosphorylation (OXPHOS) complexes I through IV.

At INNERSTANDIN, our synthesis of longitudinal biomarker data reveals that this structural compromise initiates a vicious biochemical cycle: electron leakage at complexes I and III surges, driving exponential superoxide radical generation that inflicts further damage upon proximal cardiolipin—the signature phospholipid essential for inner mitochondrial membrane integrity. The depletion of cardiolipin uncouples respiration from ATP synthesis, causing a catastrophic energetic deficit within post-mitotic tissues. Concurrently, outer mitochondrial membrane permeabilisation allows the cytosolic efflux of damage-associated molecular patterns (DAMPs), including cytosolic mtDNA and cardiolipin itself. These molecules engage innate immune pattern-recognition receptors, notably the cGAS-STIG pathway and the NLRP3 inflammasome, establishing a state of sterile, chronic low-grade systemic inflammation often termed 'inflammageing'.

This sustained pro-inflammatory milieu severely impairs macroautophagic clearance. Mitophagy—the selective degradation of dysfunctional mitochondria via PINK1-Parkin signalling—becomes blunted with age, causing an accumulation of senescent, hyper-fused networks that continually spew pro-apoptotic factors such as cytochrome c. When this cascade reaches critical mass within high-energy-demand organs, the clinical manifestations of biological aging materialise. In the myocardium, progressive bioenergetic failure leads to diastolic dysfunction and heart failure with preserved ejection fraction (HFpEF). In the central nervous system, chronic neuronal ATP deprivation compromises axonal transport and synaptic plasticity, accelerating neurodegenerative phenotypes characteristic of Alzheimer’s and Parkinson’s pathologies. Furthermore, pancreatic beta-cell exhaustion secondary to declining insulin secretory capacity highlights how localized mitochondrial decay precipitates systemic metabolic syndrome.

Ultimately, mapping this multi-systemic deterioration demonstrates that mitochondrial decay is not merely a correlate of chronological aging, but its primary biological driver. By disrupting intracellular calcium homeostasis, exhausting endogenous antioxidant reserves, and perpetually triggering innate immunity, mitochondrial dysfunction coordinates the systemic collapse of organismal resilience. Unravelling these precise mechanistic nodes remains the foremost imperative for therapeutic intervention in modern translational medicine.

What the Mainstream Narrative Omits

The prevailing bigerontological discourse has long reduced human senescence to a simplistic narrative of stochastic wear-and-tear, erroneously characterising mitochondrial decay as little more than passive oxidative collateral damage. For decades, popular science and orthodox medical literature have promoted the linear free radical theory of ageing (LFRTA), attributing cellular decline solely to the accumulation of reactive oxygen species (ROS) leaking from the electron transport chain (ETC) and indiscriminately damaging macromolecules. However, this reductionist paradigm deliberately omits the intricate, multi-layered regulatory failures and retrograde signalling dysfunctions that genuinely drive mitochondrial deterioration. Modern high-resolution metabolomic analyses and deep-sequencing transcriptomics published in journals such as The Lancet and Nature Metabolism reveal that mitochondrial decay is not merely a consequence of ageing, but a primary, actively orchestrated driver of systemic collapse, underpinned by the systematic breakdown of quality-control networks—specifically, mitophagy, mitochondrial biogenesis, and fusion-fission dynamics.

Crucially, the mainstream narrative consistently overlooks the critical role of nuclear-mitochondrial intergenomic communication. During senescence, the stoichiometric imbalance between nuclear-encoded and mitochondrial-encoded subunits of the oxidative phosphorylation (OXPHOS) complexes—exacerbated by somatic mutations in mitochondrial DNA (mtDNA) and the depletion of the mitochondrial transcription factor A (TFAM)—leads to structural destabilisation of the supercomplexes. This structural failure exponentially increases electron leakage, not as a random byproduct, but as a dysfunctional metabolic shift. Furthermore, orthodox models fail to adequately address the exhaustion of the NAD+/SIRT axis. As intracellular NAD+ levels plummet due to chronic activation of DNA repair enzymes (like PARP1) and consumption by CD38, the activity of sirtuins—particularly SIRT1 and SIRT3—is severely compromised. This halts the deacetylation-mediated activation of PGC-1$\alpha$, the master regulator of mitochondrial biogenesis, effectively trapping the cell in a downward spiral where damaged mitochondria replicate while healthy biogenesis is epigenetically silenced.

At INNERSTANDIN, we recognise that true longevity research must look beyond antioxidant supplementation—a therapeutic approach consistently invalidated by large-scale randomised controlled trials. The real pathology lies in the chronic failure of the mitochondrial permeability transition pore (mPTP) regulation and the blunting of mitophagy governed by the PINK1/Parkin pathway. When senescent cells fail to clear dysfunctional organelles, they trigger a persistent innate immune response via the cytosolic leakage of mtDNA into the cytoplasm, where it activates the cGAS-STING pathway. This ignites sterile, chronic, low-grade systemic inflammation—inflammageing—which accelerates tissue fibrosis and metabolic paralysis across diverse physiological systems. By omitting these complex epigenetic, proteostatic, and immunometabolic mechanisms, the mainstream medical establishment obscures the true molecular targets required to restore cellular bioenergetics and reverse the trajectory of biological ageing.

The UK Context

Within the United Kingdom, the clinical burden of mitochondrial decay has transformed from an obscure sub-discipline of biogerontology into a critical public health emergency. As highlighted by epidemiological data published in The Lancet, the UK’s rapidly ageing demographic—projected to see those aged 85 and over double within the next three decades—faces an exponential rise in multi-morbidity driven by bioenergetic failure. At INNERSTANDIN, our analysis of UK-centric biomedical datasets reveals that the systemic collapse of oxidative phosphorylation is not merely a correlate of chronological age, but its primary hydraulic engine. When mitochondrial networks in post-mitotic tissues—such as the myocardium, skeletal muscle, and the central nervous system—succumb to cumulative mtDNA mutations, chronic oxidative stress, and impaired mitophagy, the physiological reserve of the British population plummets, precipitating the onset of frailty, sarcopenia, and neurodegenerative cascades.

This macro-level health crisis is intricately linked to socio-economic disparities across the home nations. Research indexed in PubMed consistently demonstrates that mitochondrial mutational load and epigenetic acceleration are heavily modulated by environmental stressors, nutritional deficits, and localized socioeconomic deprivation. Industrial and urban centres in the UK exhibit disproportionately high markers of systemic inflammation and oxidative damage, which directly exacerbate the degradation of the mitochondrial electron transport chain (ETC). As complexes I through IV suffer structural compromise, adenosine triphosphate (ATP) synthesis drops precipitously while electron leak at complexes I and III accelerates the generation of reactive oxygen species (ROS). This biochemical feedback loop overwhelms endogenous antioxidant defenses—such as superoxide dismutase and glutathione peroxidase—creating a pathogenic vortex of lipid peroxidation, mtDNA fragmentation, and unprogrammed cellular necrosis.

Consequently, the UK research landscape, bolstered by initiatives from UK Research and Innovation (UKRI) and the Medical Research Council (MRC), is pivoting aggressively toward translational gerontology. Investigators are prioritizing interventions that target mitochondrial quality control, including pharmacological upregulators of NAD+ biosynthesis (such as nicotinamide riboside) and small-molecule enhancers of mitophagy. By dissecting the precise molecular kinetics of mitochondrial decay within British cohorts, science is moving past palliative disease management. At INNERSTANDIN, we emphasize that true longevity science must dismantle the bioenergetic bottlenecks of the cellular powerhouse, shifting the paradigm from the mere extension of lifespan to the aggressive reclamation of human healthspan.

Protective Measures and Recovery Protocols

Mitigating the progressive bioenergetic decline associated with mitochondrial decay demands interventions that transcend symptomatic management, targeting instead the root molecular cascades of organellar degradation. At the vanguard of clinical biogerontology is the pharmacological and nutritional upregulation of mitophagy—the selective macroautophagic clearance of dysfunctional mitochondria. Seminal investigations published in The Lancet and indexed across PubMed demonstrate that caloric restriction mimetics and specific nutraceuticals can reactivate sluggish autophagic machinery. Compounds such as urolithins, naturally produced via the gut microbial biotransformation of ellagitannins found in pomegranates, have been shown in human clinical trials to stimulate selective mitophagy, effectively purging the intracellular milieu of senescent, reactive oxygen species (ROS)-leaking mitochondria and promoting mitochondrial biogenesis.

Concurrently, restoring optimal mitochondrial membrane potential requires addressing the depletion of tricarboxylic acid (TCA) cycle intermediates and electron transport chain cofactors. Nicotinamide adenine dinucleotide ($NAD^+$) precursors, including nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), are critical in this regard. As $NAD^+$ pools inevitably contract with biological ageing, the activity of sirtuins—particularly SIRT1 and SIRT3—plummets, downregulating peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1$\alpha$), the master transcriptional regulator of mitochondrial biogenesis. Restoring $NAD^+$ bioavailability re-establishes nuclear-mitochondrial crosstalk, enhancing oxidative phosphorylation efficiency and upregulating endogenous antioxidant defences such as superoxide dismutase and glutathione peroxidase within the mitochondrial matrix.

At INNERSTANDIN, our synthesis of current UK-led translational research also emphasises the therapeutic modulation of membrane lipidomics. Cardiolipin, a signature diphosphatidylglycerol lipid unique to the inner mitochondrial membrane, is highly vulnerable to lipid peroxidation by hydroxyl radicals generated during aberrant electron transfer. When cardiolipin is oxidized, cytochrome c detaches, initiating the intrinsic apoptotic cascade. Emerging protocols utilising specific targeting antioxidants, such as MitoQ—which conjugates the lipophilic triphenylphosphonium cation to naturally occurring ubiquinone—concentrate hundreds of times within the mitochondrial lipid bilayer. This precise localisation neutralises peroxidative damage in situ, preserving cristae architecture and maintaining the proton motive force essential for ATP synthase activity.

Furthermore, systemic interventions must account for the hormetic induction of stress-response pathways. High-intensity interval training and localized thermal stress (such as infrared hyperthermia) act as mechanical and metabolic stressors that transiently increase intracellular calcium and AMP-activated protein kinase (AMPK) signalling. This initiates a hormetic cascade, compelling the cell to scrap structurally compromised networks via fission-fusion dynamics while amplifying the transcription of nuclear-encoded mitochondrial genes. Ultimately, reversing mitochondrial decay is not about passive supplementation, but about reactivating the cell’s innate quality-control networks to restore bioenergetic homeostasis and compress morbidity.

Summary: Key Takeaways

Mitochondrial decay represents the fundamental biochemical driver of systemic senescence, shifting the aging paradigm from stochastic cellular wear-and-tear to an orchestrated bioenergetic collapse. As elucidated by landmark studies in journals such as The Lancet and Nature Metabolism, progressive somatic mutations in mitochondrial DNA (mtDNA)—exacerbated by deficient proofreading capacity in DNA polymerase gamma—drive structural disintegration of the electron transport chain. This enzymatic failure precipitates an exponential escalation in reactive oxygen species (ROS) generation, establishing a cytotoxic feedback loop that inflicts oxidative damage upon lipids, proteins, and the mitochondrial genome itself. Consequently, diminished ATP synthesis starves high-demand post-mitotic tissues, while aberrant permeabilisation of the inner mitochondrial membrane triggers the cytosolic release of damage-associated molecular patterns (DAMPs), chronic sterile inflammation (inflammageing), and apoptotic cascades. At INNERSTANDIN, our rigorous interrogation of these molecular pathways demonstrates that arresting biological aging requires therapeutic strategies focused on restoring mitophagy, enhancing NAD+ dependent sirtuin signalling, and reversing age-related bioenergetic decline.